StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Abbott Labs (ABT) PT Raised to $140 at Cowen
January 27, 2021 4:24 PM
Cowen analyst Joshua Jennings raised the price target on Abbott Labs (NYSE: ABT) to $140.00 (from $113.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Form 8-K ABBOTT LABORATORIES For: Jan 27
January 27, 2021 7:42 AM
Abbott (ABT) Tops Q1 EPS by 10c, Offers FY Guidance
January 27, 2021 7:35 AM
Abbott Reports Fourth-Quarter 2020 Results; Issues Strong Double-Digit Growth Forecast for 2021
January 27, 2021 7:30 AM
Abbott (ABT) call put ratio 6.6 calls to 1 put into quarter release and outlook
January 26, 2021 10:16 AM
Abbott's (ABT) Panbio Rapid Antigen Test Receives CE Mark for Asymptomatic Screening and Self-Administered Sample Collection with Nasal Swab
January 26, 2021 7:45 AM
Abbott's Panbio Rapid Antigen Test Receives CE Mark for Asymptomatic Screening and Self-Administered Sample Collection with Nasal Swab
January 26, 2021 7:45 AM
12-Month Data from Surmodics’ TRANSCEND Trial Presented at LINC 2021 Event
January 25, 2021 8:25 AM
